Immunometabolism markers such as leptin have been associated with cellular and molecular mechanisms linking obesity to white adipose tissue (WAT) dysfunction, which in turn promotes a broad spectrum of metabolic (cardiovascular, diabetes) and/or inflammatory associated disorders (chronic pain, neuropsychiatric disorders). Here, LEP is linked to diabetes mellitus.